Intracoronary continuous adenosine infusion: A novel and effective way of inducing maximal hyperemia for fractional flow reserve measurement

Circulation Journal

Volumn 69, Issue 8, 2005, Pages 908-912

  Koo, Bon Kwon ^a   Kim, Cheol Ho ^b   Na, Sang Hun ^a   Youn, Tae Jin ^b   Chae, In Ho ^b   Choi, Dong Ju ^b   Kim, Hyo Soo ^a   Lee, Myoung Mook ^a   Byung Hee, ^a   Park, Young Bae ^a   Choi, Yun Shik ^a   Tahk, Seung Jae ^c  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Adenosine; Fractional flow reserve; Hyperemia

Indexed keywords

ADENOSINE;

ADULT; AGED; ARTICLE; BLOOD FLOWMETRY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEMODYNAMIC PARAMETERS; HUMAN; HYPEREMIA; INTRACORONARY INFUSION; MALE; SAFETY; STATISTICAL SIGNIFICANCE; TECHNIQUE;

ADENOSINE; AGED; BLOOD FLOW VELOCITY; CORONARY CIRCULATION; CORONARY STENOSIS; FEMALE; HUMANS; HYPEREMIA; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED;

EID: 23744447493     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.69.908     Document Type: Article

References (21)

1. Kern MJ, Donohue TJ, Aguirre FV. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol 1995; 25: 178-187.
2. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurement and exercise-induced myocardial ischemia. Circulation 1995; 92: 39-46.
3. Pijls NHJ, De Bruyne B, Peels K, van der Voort PH, Bonnier HJRM, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. N Engl J Med 1996; 334: 1703-1708.
4. Pijls NHJ, Klauss V, Siebert U, Powers E, Takazawa K, Fearon WF, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up. Circulation 2002; 105: 2950-2954.
5. Kern MJ, De Bruyne B, Pijls NHJ. From research to clinical practice: Current role of intracoronary physiologically based decision making in the cardiac catheterization laboratory. J Am Coll Cardiol 1997; 30: 613-620.
6. De Bruyne B, Bartunek J, Sys SU, Pijls NHJ, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans: Feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index and fractional flow reserve. Circulation 1996; 94: 1842-1849.
7. Yanagisawa H, Chikamori T, Tanaka N, Hatano T, Morishima T, Hida S, et al. Correlation between thallium-201 myocardial perfusion defects and the functional severity of coronary artery stenosis as assessed by pressure-derived myocardial fractional flow reserve. Circ J 2002; 66: 1105-1109.
8. Yanagisawa H, Chikamori T, Tanaka N, Usui Y, Takazawa K, Yamashita A. Application of pressure-derived myocardial fractional flow reserve in assessing the functional severity of coronary artery stenosis in patients with diabetes mellitus. Circ J 2004; 68: 993-998.
9. Pijls NHJ, Van Son JAM, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after PTCA. Circulation 1993; 87: 1354-1367.
10. De Bruyne B, Pijls NHJ, Barbato E, Bartunek J, Bech J-W, Wijns W, et al. Intracoronary and intravenous adenosine 5′-triphosphaste, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans. Circulation 2003; 107: 1877-1883.
11. Nanto S, Kitakaze M, Takano Y, Hori M, Magata S. Intracoronary administration of adenosine triphosphate increase myocardial adenosine levels and coronary blood flow in man. Jpn Circ J 1997; 10: 836-842.
12. Tanake N, Takazawa K, Takeda K, Aikawa M, Shindo N, Amaya K, et al. Coronary flow-pressure relationship distal to epicardial stenosis. Circ J 2003; 67: 525-529.
13. Di Segni E, Hgano ST, Rihal CS, Holmes DR Jr, Lennon R, Lerman A. Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making. Cathet Cardiovasc Interv 2001; 54: 34-40.
14. Lopez-Palop R, Saura D, Pinar E, Lozano I, Perez-Lorente F, Pico F, et al. Adequate intracoronary adenosine doses to achieve maximum hyperaemia in coronary functional studies by pressure derived fractional flow reserve: A dose response study. Heart 2004; 90: 95-96.
15. De Bruyne B, Pijls NHJ, Bartunek J, Kulecki J, Bech J-W, De Winter H, et al. Fractional flow reserve in patients with prior myocardial infarction. Circulation 2001; 104: 157-162.
16. Wilson RF, Wyche K, Christensen BV, Zimmer S, Laxson DD. Effects of adenosine on human coronary arterial circulation. Circulation 1990; 82: 1595-1606.
17. van der Voort PH, van Hagen E, Hendrikx GR, van Gelder B, Bech JW, Pijls NHJ. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Cathet Cardiovasc Diagn 1996; 39: 120-125.
18. Casella G, Rieber J, Schiele TM, Stempfle HU, Siebert U, Leibig M, et al. A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve. Z Kardiol 2003; 92: 627-632.
19. De Bruyne B, Pijls NHJ, Smith L, Wievegg M, Heyndrickx GR. Coronary thermodilution to assess flow reserve: Experimental validation. Circulation 2001; 104: 2003-2006.
20. Pijls NHJ, De Bruyne B, Smith L, Wievegg M, Heyndrickx GR. Coronary thermodilution to assess flow reserve: Validation in humans. Circulation 2002; 105: 2482-2486.
21. Fearon WF, Farouque HM, Balsam LB, Caffarelli AD, Cooke DT, Robbins RC, et al. Comparison of coronary thermodilution and Doppler velocity for assessing coronary flow reserve. Circulation 2003; 108: 2198-2200.